| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 49,847 | 49,698 | 50,702 | 52,003 | | Cost of Revenue | 8,743 | 9,921 | 9,454 | 9,886 | | | Gross Profit |
-
| 39,777 | 41,248 | 42,117 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 25,519 | 25,811 | 23,195 | 24,221 | | Non Recurring |
-
|
-
|
-
| 1,909 | | Others | 35,498 | 11,662 | 11,668 | 18,894 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 2,304 | 6,385 | (2,907) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (19,913) | 2,304 | 6,385 | (2,907) | | Interest Expense | 4,040 | 4,299 | 4,249 | 4,470 | | Income Before Tax | (23,953) | (1,995) | 2,136 | (7,377) | | Income Tax Expense | (10,379) | (1,715) | (81) | (3,941) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (13,574) | (280) | 2,217 | (3,436) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (13,574) | (280) | 2,217 | (3,436) | | Preferred Stock And Other Adjustments | (1,205) | (1,202) | (1,200) | (334) | | | Net Income Applicable To Common Shares | ($14,779) | ($1,482) | $1,017 | ($3,770) |
|
0.03% Nasdaq 
Income Statement
